Tsuruha Holdings (3391) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
6 Jun, 2025Executive summary
Fiscal period was shortened to 9.5 months due to a change in fiscal year-end, making direct year-over-year comparisons unavailable; reference values for the previous 12-month period are provided.
Economic environment showed moderate recovery, but consumer spending remained sluggish due to rising prices and continued savings trends.
Tsuruha Holdings focused on store strategy, pharmacy enhancement, private brand development, and digital transformation to drive growth.
Group ended the period with 2,658 domestic stores and 22 overseas stores, after 73 new openings and 68 closures.
Financial highlights
Net sales: ¥845.6 billion for the 9.5-month period (previous 12 months: ¥1,027.5 billion).
Operating income: ¥37.9 billion (previous: ¥47.2 billion); ordinary income: ¥37.8 billion (previous: ¥47.5 billion).
Net income attributable to owners: ¥17.2 billion (previous: ¥21.7 billion).
Gross profit: ¥257.5 billion; gross margin approximately 30.5%.
Earnings per share: ¥353.67 (previous: ¥447.27).
Outlook and guidance
FY2026 (12 months) forecast: net sales ¥1,113.4 billion, operating income ¥51.1 billion, ordinary income ¥50.3 billion, net income attributable to owners ¥24.8 billion, EPS ¥509.59.
Annual dividend forecast for FY2026: ¥267 per share, unchanged from FY2025.
Company will continue to focus on store, pharmacy, PB, and DX strategies to improve profitability.
Latest events from Tsuruha Holdings
- Nine-month net sales were ¥833,383 million, with WELCIA integration completed.3391
Q3 20268 Jan 2026 - Profits and sales beat targets, with integration and stock split amid sector challenges.3391
Q2 202610 Dec 2025 - Net sales and operating income surpassed targets amid robust food and pharmacy growth and integration plans.3391
Q1 202610 Jul 2025 - Transitional period saw solid sales and profit, with FY2026 guidance projecting further growth.3391
Q4 202530 Jun 2025 - Q1 profit and sales rose, outlook steady despite one-time costs from fiscal year change.3391
Q1 202513 Jun 2025 - Sales rose 5.9% but net income dipped on impairment; FY2025 outlook is for strong profit growth.3391
Q4 202413 Jun 2025 - Net income fell sharply despite higher sales, driven by impairment and store closure losses.3391
Q2 20255 Jun 2025